This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryo, A.
Right arrow Articles by Lu, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryo, A.
Right arrow Articles by Lu, K. P.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2002, p. 5281-5295, Vol. 22, No. 15
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.15.5281-5295.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells

Akihide Ryo, Yih-Cherng Liou, Gerburg Wulf, Masafumi Nakamura, Sam W. Lee, and Kun Ping Lu*

Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215

Received 19 February 2002/ Returned for modification 2 April 2002/ Accepted 22 April 2002

Oncogenes Neu/HER2/ErbB2 and Ras can induce mammary tumorigenesis via upregulation of cyclin D1. One major regulatory mechanism in these oncogenic signaling pathways is phosphorylation of serines or threonines preceding proline (pSer/Thr-Pro). Interestingly, the pSer/Thr-Pro motifs in proteins exist in two completely distinct cis and trans conformations, whose conversion is catalyzed specifically by the essential prolyl isomerase Pin1. By isomerizing pSer/Thr-Pro bonds, Pin1 can regulate the conformation and function of certain phosphorylated proteins. We have previously shown that Pin1 is overexpressed in breast tumors and positively regulates cyclin D1 by transcriptional activation and posttranslational stabilization. Moreover, in Pin1 knockout mice, mammary epithelial cells fail to undergo massive proliferation during pregnancy, as is the case in cyclin D1 null mice. These results indicate that Pin1 is upregulated in breast cancer and may be involved in mammary tumors. However, the mechanism of Pin1 overexpression in cancer and its significance in cell transformation remain largely unknown. Here we demonstrate that PIN1 expression is mediated by the transcription factor E2F and enhanced by c-Neu and Ha-Ras via E2F. Furthermore, overexpression of Pin1 not only confers transforming properties on mammary epithelial cells but also enhances the transformed phenotypes of Neu/Ras-transformed mammary epithelial cells. In contrast, inhibition of Pin1 suppresses Neu- and Ras-induced transformed phenotypes, which can be fully rescued by overexpression of a constitutively active cyclin D1 mutant that is refractory to the Pin1 inhibition. Thus, Pin1 is an E2F target gene that is essential for the Neu/Ras-induced transformation of mammary epithelial cells through activation of cyclin D1.

* Corresponding author. Mailing address: Harvard Institutes of Medicine, Room 1047, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215. Phone: (617) 667-4143. Fax: (617) 667-0610. E-mail: klu{at}caregroup.harvard.edu.

Molecular and Cellular Biology, August 2002, p. 5281-5295, Vol. 22, No. 15
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.15.5281-5295.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lu, J., Hu, Z., Wei, S., Wang, L.-E, Liu, Z., El-Naggar, A. K., Sturgis, E. M., Wei, Q. (2009). A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis 30: 1717-1721 [Abstract] [Full Text]  
  • Zhou, W., Yang, Q., Low, C. B., Karthik, B. C., Wang, Y., Ryo, A., Yao, S. Q., Yang, D., Liou, Y.-C. (2009). Pin1 Catalyzes Conformational Changes of Thr-187 in p27Kip1 and Mediates Its Stability through a Polyubiquitination Process. J. Biol. Chem. 284: 23980-23988 [Abstract] [Full Text]  
  • Ai, Z., Zhang, W., Luo, W., Huang, L., Pan, Y. (2009). Expression of Pin1 mRNA in Non-Small-Cell Lung Cancer Patients. Asian Cardiovasc. Thorac. Ann. 17: 157-161 [Abstract] [Full Text]  
  • Peloponese, J.-M. Jr., Yasunaga, J., Kinjo, T., Watashi, K., Jeang, K.-T. (2009). Peptidylproline cis-trans-Isomerase Pin1 Interacts with Human T-Cell Leukemia Virus Type 1 Tax and Modulates Its Activation of NF-{kappa}B. J. Virol. 83: 3238-3248 [Abstract] [Full Text]  
  • Lee, N. Y., Choi, H.-K., Shim, J.-H., Kang, K.-W., Dong, Z., Choi, H. S. (2009). The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation. Carcinogenesis 30: 671-681 [Abstract] [Full Text]  
  • Stanya, K. J., Liu, Y., Means, A. R., Kao, H.-Y. (2008). Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. JCB 183: 49-61 [Abstract] [Full Text]  
  • Brenkman, A. B., de Keizer, P. L.J., van den Broek, N. J.F., van der Groep, P., van Diest, P. J., van der Horst, A., Smits, A. M.M., Burgering, B. M.T. (2008). The Peptidyl-Isomerase Pin1 Regulates p27kip1 Expression through Inhibition of Forkhead Box O Tumor Suppressors. Cancer Res. 68: 7597-7605 [Abstract] [Full Text]  
  • Reineke, E. L., Lam, M., Liu, Q., Liu, Y., Stanya, K. J., Chang, K.-S., Means, A. R., Kao, H.-Y. (2008). Degradation of the Tumor Suppressor PML by Pin1 Contributes to the Cancer Phenotype of Breast Cancer MDA-MB-231 Cells. Mol. Cell. Biol. 28: 997-1006 [Abstract] [Full Text]  
  • Tannapfel, A., John, K., Mise, N., Schmidt, A., Buhlmann, S., Ibrahim, S. M., Putzer, B. M. (2008). Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73. Carcinogenesis 29: 211-218 [Abstract] [Full Text]  
  • Perez de Castro, I., de Carcer, G., Malumbres, M. (2007). A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis 28: 899-912 [Abstract] [Full Text]  
  • Louie, M. C., Revenko, A. S., Zou, J. X., Yao, J., Chen, H.-W. (2006). Direct Control of Cell Cycle Gene Expression by Proto-Oncogene Product ACTR, and Its Autoregulation Underlies Its Transforming Activity. Mol. Cell. Biol. 26: 3810-3823 [Abstract] [Full Text]  
  • Schweiger, M.-R., You, J., Howley, P. M. (2006). Bromodomain Protein 4 Mediates the Papillomavirus E2 Transcriptional Activation Function. J. Virol. 80: 4276-4285 [Abstract] [Full Text]  
  • Suizu, F., Ryo, A., Wulf, G., Lim, J., Lu, K. P. (2006). Pin1 Regulates Centrosome Duplication, and Its Overexpression Induces Centrosome Amplification, Chromosome Instability, and Oncogenesis. Mol. Cell. Biol. 26: 1463-1479 [Abstract] [Full Text]  
  • Yeh, E. S., Lew, B. O., Means, A. R. (2006). The Loss of PIN1 Deregulates Cyclin E and Sensitizes Mouse Embryo Fibroblasts to Genomic Instability. J. Biol. Chem. 281: 241-251 [Abstract] [Full Text]  
  • Ryo, A., Uemura, H., Ishiguro, H., Saitoh, T., Yamaguchi, A., Perrem, K., Kubota, Y., Lu, K. P., Aoki, I. (2005). Stable Suppression of Tumorigenicity by Pin1-Targeted RNA Interference in Prostate Cancer. Clin. Cancer Res. 11: 7523-7531 [Abstract] [Full Text]  
  • Hong, J. W., Ryu, M. S., Lim, I. K. (2005). Phosphorylation of Serine 147 of tis21/BTG2/pc3 by p-Erk1/2 Induces Pin-1 Binding in Cytoplasm and Cell Death. J. Biol. Chem. 280: 21256-21263 [Abstract] [Full Text]  
  • Edgar, K. A., Belvin, M., Parks, A. L., Whittaker, K., Mahoney, M. B., Nicoll, M., Park, C. C., Winter, C. G., Chen, F., Lickteig, K., Ahmad, F., Esengil, H., Lorenzi, M. V., Norton, A., Rupnow, B. A., Shayesteh, L., Tabios, M., Young, L. M., Carroll, P. M., Kopczynski, C., Plowman, G. D., Friedman, L. S., Francis-Lang, H. L. (2005). Synthetic Lethality of Retinoblastoma Mutant Cells in the Drosophila Eye by Mutation of a Novel Peptidyl Prolyl Isomerase Gene. Genetics 170: 161-171 [Abstract] [Full Text]  
  • Bao, L., Kimzey, A., Sauter, G., Sowadski, J. M., Lu, K. P., Wang, D.-G. (2004). Prevalent Overexpression of Prolyl Isomerase Pin1 in Human Cancers. Am. J. Pathol. 164: 1727-1737 [Abstract] [Full Text]  
  • Schubert, A., Grimm, S. (2004). Cyclophilin D, a Component of the Permeability Transition-Pore, Is an Apoptosis Repressor. Cancer Res. 64: 85-93 [Abstract] [Full Text]  
  • Ayala, G., Wang, D., Wulf, G., Frolov, A., Li, R., Sowadski, J., Wheeler, T. M., Lu, K. P., Bao, L. (2003). The Prolyl Isomerase Pin1 Is a Novel Prognostic Marker in Human Prostate Cancer. Cancer Res. 63: 6244-6251 [Abstract] [Full Text]  
  • Zhang, G., He, B., Weber, G. F. (2003). Growth Factor Signaling Induces Metastasis Genes in Transformed Cells: Molecular Connection between Akt Kinase and Osteopontin in Breast Cancer. Mol. Cell. Biol. 23: 6507-6519 [Abstract] [Full Text]  
  • Jacobs, D. M., Saxena, K., Vogtherr, M., Bernado, P., Pons, M., Fiebig, K. M. (2003). Peptide Binding Induces Large Scale Changes in Inter-domain Mobility in Human Pin1. J. Biol. Chem. 278: 26174-26182 [Abstract] [Full Text]  
  • Ryo, A., Liou, Y.-C., Lu, K. P., Wulf, G. (2003). Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J. Cell Sci. 116: 773-783 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»